From: Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
Compounds
GPCR ligand
Ion channel modulator
Kinase inhibitor
Nuclear receptor ligand
Protease inhibitor
Enzyme inhibitor
13
0.17
− 0.02
0.06
− 0.39
0.09
− 0.06
21
0.32
0.21
0.26
− 0.44
0.16
0.10